Some of the world’s top makers of coronavirus vaccines said that they’re already working at an accelerated pace to battle omicron, studying the new variant and aiming to adapt their products to protect against this latest mutation, Newsmax reports.

Pfizer and BioNTech said they are investigating omicron. They said that they believe their vaccine can be adapted quickly should it be needed to curb the spread.

“We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529,” the companies said.

CNBC said that according to Pfizer and BioNTech, more data from lab tests is anticipated in two weeks at the outside.... Read More: Newsmax